A detailed history of Wescott Financial Advisory Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Wescott Financial Advisory Group, LLC holds 16,679 shares of OGN stock, worth $241,011. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,679
Previous 18,637 10.51%
Holding current value
$241,011
Previous $356,000 30.34%
% of portfolio
0.03%
Previous 0.04%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$14.44 - $18.83 $28,273 - $36,869
-1,958 Reduced 10.51%
16,679 $248,000
Q3 2024

Nov 12, 2024

SELL
$18.65 - $23.03 $223 - $276
-12 Reduced 0.06%
18,637 $356,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $2,128 - $2,679
-122 Reduced 0.65%
18,649 $386,000
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $9,866 - $13,460
-716 Reduced 3.67%
18,771 $352,000
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $5,321 - $8,417
486 Added 2.56%
19,487 $281,000
Q3 2023

Nov 09, 2023

BUY
$16.59 - $23.77 $2,223 - $3,185
134 Added 0.71%
19,001 $329,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $4,277 - $5,467
222 Added 1.19%
18,867 $392,000
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $556 - $834
26 Added 0.14%
18,645 $438,000
Q4 2022

Feb 06, 2023

BUY
$23.31 - $28.61 $4,941 - $6,065
212 Added 1.15%
18,619 $520,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $27,378 - $40,072
1,170 Added 6.79%
18,407 $431,000
Q2 2022

Jul 28, 2022

BUY
$31.66 - $38.9 $89,724 - $110,242
2,834 Added 19.68%
17,237 $582,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $438,571 - $566,902
14,403 New
14,403 $503,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.68B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Wescott Financial Advisory Group, LLC Portfolio

Follow Wescott Financial Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wescott Financial Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wescott Financial Advisory Group, LLC with notifications on news.